• The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures 

      Moorkens, Evelien; Godman, Brian; Huys, Isabelle; Hoxha, Iris; Malaj, Admir; Keuerleber, Simon; Stockinger, Silvia; Mörtenhuber, Sarah; Dimitrova, Maria; Tachkov, Konstantin; Vončina, Luka; Palčevski, Vera Vlahović; Achniotou, Gnosia; Slabý, Juraj; Popelková, Leona; Kohoutová, Kateřina; Bartels, Dorthe; Laius, Ott; Martikainen, Jaana E.; Selke, Gisbert; Kourafalos, Vasileios; Magnusson, Einar; Einarsdóttir, Rannveig; Adams, Roisín; Joppi, Roberta; Allocati, Eleonora; Jakupi, Arianit; Viksna, Anita; Greičiūtė-Kuprijanov, Ieva; Vella Bonanno, Patricia; Suttorp, Vincent; Melien, Øyvind; Plisko, Robert; Mardare, Ileana; Meshkov, Dmitry; Novakovic, Tanja; Fürst, Jurij; Zara, Corrine; Markovic-Pekovic, Vanda; Grubiša, Nataša; Befrits, Gustaf; Puckett, Robert; Vulto, Arnold G. (Peer reviewed; Journal article, 2021)